Epstein-Barr Virus Early Antigen D Antibody (IgG)
Test Code
15447
86663
Clinical Significance
Epstein-Barr Virus Early Antigen D Antibody (IgG) - Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. IgG recognizing Early Antigen D typically appears within a month after clinical presentation and is transient, lasting only 3-4 months. Persistently elevated levels suggest reactivation or persistence of EBV infection.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Immunoassay (IA)
Reference Range(s)
| U/mL | Interpretation |
| <9.00 | Negative |
| 9.00-10.99 | Equivocal |
| >10.99 | Positive |
Alternative Name(s)
EBV Early Antigen Diffuse Antibody,EBV EA-D Antibody
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 4 days
- Refrigerated: 7 days
- Frozen: 30 days
Setup Schedule
1 mL serum
0.5 mL
Transport tube
Room temperature
Room temperature: 4 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days